by Laura French
As Q1 2022 comes to a close, the COVID-19 pandemic remains at the forefront of many clinical labs’ concerns more than two years after the first U.S. lockdowns. This ongoing battle against the virus and its variants, including the highly contagious Omicron, has brought about new challenges and lessons that have changed the way many clinical labs approach equipment purchases and supply chain issues. In working to connect labs with the technologies and supplies they need during this time, Tarlan Zaltash, Medline Vice President of Corporate Accounts, and Brett Miller, Senior Laboratory Sales Specialist, have had their fingers on the pulse of these evolving trends, with Medline recently expanding its laboratory segment to include a portfolio of 120,000 products and nearly 100 lab vendor partnerships. Labcompare recently spoke with Zaltash and Miller to discuss some of the most prominent topics in the clinical lab space for 2022, including questions and solutions that will likely remain relevant for many years to come.
Read more on Labcompare.